Etude peropératoire de la Perfusion Sanguine Des Carcinomes Basocellulaires Par Imageur Laser Doppler, au Cours de la Manipulation de l'Influx artériel Tumoral - Recherche d'un phénomène d'hyperémie Tumorale Post-occlusive
18 Years
N/A
Both
Carcinoma, Basal Cell
Trial Information
Etude peropératoire de la Perfusion Sanguine Des Carcinomes Basocellulaires Par Imageur Laser Doppler, au Cours de la Manipulation de l'Influx artériel Tumoral - Recherche d'un phénomène d'hyperémie Tumorale Post-occlusive
Inclusion Criteria:
- Age ≥ 18
- Histologically proved cutaneous BCC
- Patient being informed and having signed the consent to participate to the study
Exclusion Criteria:
- Counter-indication to surgery
- Patient being unable to attend future follow-up visits
- Patient with severe cognitive impairment
- Patient not affiliated to a social security regimen
- Patient with limb BCC and history of peripheral vascular artery surgery like bypass
and/or vascular prothesis on the same limb (tourniquet counter-indication)
- Local bone invasion of BCC detected with imagery
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label
Outcome Measure:
Evaluation of blood perfusion of tumor as ROI (Region Of Interest)
Outcome Description:
Evaluation of blood perfusion of tumor as ROI (Region Of Interest)in unit of laser doppler perfusion, analyzed by the software Pimsoft with the imager laser doppler Pericam PSI system of Perimed.
Outcome Time Frame:
5 months
Safety Issue:
No
Principal Investigator
GUILHARD Thierry, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
INSTITUT CURIE - HOPITAL RENE HUGUENIN
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
IC 2011-01
NCT ID:
NCT01455363
Start Date:
June 2011
Completion Date:
October 2011
Related Keywords:
- Carcinoma, Basal Cell
- Carcinoma
- Carcinoma, Basal Cell
- Hyperemia
Name | Location |
|---|
